Klingenberg R, Stahli BE, Heg D, Denegri A, et al. Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial. Am Heart J 2022 Jan 26. pii: S0002-8703(22)00010.
PMID: 35092722